HOME About Santen News Investor Relations Products Careers  
 

The 96th Annual General Meeting of Shareholders

About the Annual General Meeting 2008


Santen Pharmaceutical Co., Ltd. held its 96th Annual General Meeting of Shareholders on June 25, 2008. The Meeting started at 10:00 a.m. and ended at 11:13 a.m. The number of shareholders attended was 168.


Matters reported:
1. Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 96th Business Term (April 1, 2007 to March 31, 2008)
2. Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 96th Business Term ( April 1, 2007 to March 31, 2008)


Questions:
Questions regarding oversea business, new drug candidates, manufacturing issues and medium-term management plan were answered.


Matters resolved:
Five items of business as described below were all resolved.

Resolution [PDF:16KB]


Questions:
Question regarding Proposal 2 (Appointment of Directors) and Proposal 4 (Issuance of the Rights to Subscribe for New Shares as Stock Option for the Directors) were answered.


Back to top
 
Research & Development
Share Price
20-minute delayed share price and charts.

Provided by MONEX, Inc.
Download Adobe® Reader® to view PDF files.
  Get Adobe Reader